Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genital Neoplasms, Female × Ipilimumab × NET × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 4 Carcinoma, Neuroendocrine 3 Small Cell Lung Carcinoma 1 Genital Neoplasms, Female 1 Gastro-enteropancreatic neuroendocrine tumor 1 Carcinoid Tumor 1

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04969887 2026-02-27

MOST-CIRCUIT

Olivia Newton-John Cancer Research Institute

Phase 2 Active not recruiting

Genital Neoplasms, Female, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡